Location History:
- Mitry Mory, FR (1984 - 1999)
- Villeparisis, FR (1991 - 2018)
Company Filing History:
Years Active: 1984-2018
Title: Bruno Bonnemain: Innovator in Pharmaceutical Formulations
Introduction
Bruno Bonnemain, an accomplished inventor based in Villeparisis, France, holds a remarkable portfolio of eight patents. His innovative contributions primarily focus on pharmaceutical formulations, specifically in the development of contrast agents that enhance medical imaging techniques.
Latest Patents
One of Bruno Bonnemain's most significant inventions involves a process for preparing a liquid pharmaceutical formulation containing a complex of macrocyclic chelate with a lanthanide. This advanced formulation features a precise mol/mol amount of free macrocyclic chelate, which is crucial for its efficacy. The process entails several key steps, beginning with the preparation of a liquid pharmaceutical composition that incorporates both the complex of macrocyclic chelate and free macrocyclic chelate and/or free lanthanide. This is followed by careful measurement of the concentrations within the pharmaceutical formulation, ensuring that the target concentrations are achieved for optimal performance.
Career Highlights
Bonnemain's expertise in pharmaceutical development has been honed through his affiliation with prestigious companies such as Guerbet S.A., where he has played a pivotal role in advancing medical imaging technologies. His work not only reflects his innovative spirit but also his commitment to enhancing patient care through better diagnostic solutions.
Collaborations
In his career, Bruno has collaborated with notable professionals like Dominique Meyer and Didier Doucet, sharing knowledge and driving innovation in the pharmaceutical industry. These partnerships have been instrumental in refining the processes and products that are vital in medical applications.
Conclusion
Bruno Bonnemain exemplifies the spirit of innovation within the pharmaceutical field, with his patents contributing significantly to the development of enhanced contrast agents. His work ensures that medical professionals have access to effective tools for improved diagnostics, ultimately benefiting patient outcomes in healthcare.